Literature DB >> 7362324

Cardiovascular status after repair by Fontan procedure.

D M Behrendt, A Rosenthal.   

Abstract

Patients surviving a Fontan operation experience dramatic symptomatic improvement, but concern remains about the long-term results of this operation. The clinical course and postoperative hemodynamic findings in 5 long-term survivors of the Fontan procedure from our institution are presented. Attention is drawn to 3 patients who required reoperation: 1 immediately for residual mild pulmonary stenosis, 1 for late onset complete heart block, and 1 for conduit valve stenosis. Review of our patients and those described in the literature reveals that all have ascites and pleural effusions as a results of high venous pressures but that this is usually a temporary problem. Late onset of obstruction to right atrial emptying has been reported in several patients in addition to ours. This raises serious concerns about the long-term fate of cloth conduits and porcine valves in this application. Although normal sinus rhythm has been thought to be essential for adequate pulmonary perfusion in these patients, it is interesting that several patients have tolerated atrial tachyarrhythmias, junctional rhythms, and even complete heart block without serious ill effects. We conclude that the Fontan procedure is extremely effective in relieving symptoms at an operative risk that is now acceptable, but these patients require very careful long-term follow-up because they are subject to a number of long-term complications.

Entities:  

Mesh:

Year:  1980        PMID: 7362324     DOI: 10.1016/s0003-4975(10)61479-8

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  12 in total

1.  Recent modifications of the fontan procedure for complex congenital heart disease.

Authors:  G J Reul; I D Gregoric
Journal:  Tex Heart Inst J       Date:  1992

2.  A model to simulate the haemodynamic effects of right heart pulsatile flow after modified Fontan procedure.

Authors:  S Tamaki; K Kawazoe; T Yagihara; T Abe
Journal:  Br Heart J       Date:  1992-02

3.  Assessment of left ventricular function before and after Fontan's operation for the correction of tricuspid atresia. Changes in left ventricular function determined by left ventricular volume change.

Authors:  S Nakae; Y Imai; Y Harada; K Sawatari; M Kawada; Y Takanashi; K Ishihara; A Hashimoto; H Hayashi; H Koyanagi
Journal:  Heart Vessels       Date:  1985-05       Impact factor: 2.037

4.  A successful repair of tricuspid atresia by modified Björk's procedure--a case report.

Authors:  Y Kawachi; K Tokunaga; T Aso; J Tanaka; K Matsui; M Komori
Journal:  Jpn J Surg       Date:  1983-07

5.  Left ventricular characteristics during exercise in patients after Fontan's operation for tricuspid atresia.

Authors:  C Kondoh; M Hiroe; T Nakanishi; M Nakazawa; S Nakae; Y Imai; A Takao
Journal:  Heart Vessels       Date:  1988       Impact factor: 2.037

6.  Dysrhythmias after the modified Fontan procedure.

Authors:  S C Chen; S Nouri; D G Pennington
Journal:  Pediatr Cardiol       Date:  1988       Impact factor: 1.655

7.  Fontan operation: modification of the valve position in conduit with brief review of the literature.

Authors:  A H Sabbagh; M Riveros; J M Fritz; J Fernandez
Journal:  Tex Heart Inst J       Date:  1983-06

8.  Histopathologic abnormalities of the sinus node compared with electrocardiographic evidence of sinus node dysfunction after the modified Fontan operation: an autopsy study of 14 cases.

Authors:  D P Chan; D A Bartmus; W D Edwards; C B Porter
Journal:  Tex Heart Inst J       Date:  1992

9.  Cerebral infarction complicating Fontan surgery for cyanotic congenital heart disease.

Authors:  K Mathews; J F Bale; E B Clark; W J Marvin; D B Doty
Journal:  Pediatr Cardiol       Date:  1986       Impact factor: 1.655

10.  Intracardiac causes of superior vena cava obstruction.

Authors:  A J Rein; I Yatsiv; A Simcha
Journal:  Eur J Pediatr       Date:  1988-11       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.